Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FIBRYGA safely and effectively. See full prescribing information for FIBRYGA. FIBRYGA® [fibrinogen (human)] Lyophilized Powder for Reconstitution, For Intravenous Use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-other
FIBRYGA is indicated for fibrinogen supplementation in bleeding patients with acquired fibrinogen deficiency. FIBRYGA is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Limitations of Use: FIBRYGA is not indicated for dysfibrinogenemia.
- generic_name
- fibrinogen (human)
- product_names
- Fibrinogen (Human)
- ndc
- 68982-350, 68982-350-81, 68982-350-01, 68982-349, 68982-349-81, 68982-349-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en